Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Q1 2025 Earnings Call Transcript April 22, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $11.97, ...

Discover Elevance Health's Q1 2025 performance with EPS growth, operational milestones, and strategic investments.

Q1 2025 Earnings Conference Call April 22, 2025 8:30 AM ETCompany ParticipantsNathan Rich - VP, IRGail Boudreaux ...

Elevance Health saw net income fall 2.9% to $2.2 billion during the first quarter, the insurer announced Tuesday.

On April 17, Joyce Chang, JPMorgan chair of global research, appeared on CNBC’s ‘Closing Bell Overtime’ to talk about ...

Health insurance provider Elevance Health (NYSE:EVH) reported in Q1 CY2025, with sales up 14.5% year on year to $48.77 ...

Elevance also reiterated its full-year profit forecast of $34.15 to $34.85 per share, and reported first-quarter adjusted ...

High Medicare Advantage spending continues to dog major carriers such as Elevance Health and UnitedHealth Group.

Shares of UnitedHealth and Elevance Health rose about 6% in after hours ... As insurers "review the new policies released in the last two days, they will continue to focus on helping ...

In its first quarter 2025 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits company ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $512.00. The company’s shares closed yesterday at $435.68.